RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Ramesh Badisa to Antineoplastic Agents

This is a "connection" page, showing publications Ramesh Badisa has written about Antineoplastic Agents.
Connection Strength

0.590
  1. Badisa RB, Mina DA, Latinwo LM, Soliman KF. Selective anticancer activity of neurotoxin 1-methyl-4-phenylpyridinium on non-small cell lung adenocarcinoma A549 cells. Anticancer Res. 2014 Oct; 34(10):5447-52.
    View in: PubMed
    Score: 0.289
  2. Badisa RB, Darling-Reed SF, Joseph P, Cooperwood JS, Latinwo LM, Goodman CB. Selective cytotoxic activities of two novel synthetic drugs on human breast carcinoma MCF-7 cells. Anticancer Res. 2009 Aug; 29(8):2993-6.
    View in: PubMed
    Score: 0.202
  3. Gangapuram M, Jean R, Mazzio E, Badisa R, Eyunni S, Goodman CB, Redda KK, Soliman KF. Substituted Tetrahydroisoquinolines as Microtubule-destabilizing Agents in Triple Negative Human Breast Cancer Cells. Anticancer Res. 2016 10; 36(10):5043-5052.
    View in: PubMed
    Score: 0.083
  4. Hardaway CM, Badisa RB, Soliman KF. Effect of ascorbic acid and hydrogen peroxide on mouse neuroblastoma cells. Mol Med Rep. 2012 06; 5(6):1449-52.
    View in: PubMed
    Score: 0.015
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support